temoporfin has been researched along with fenretinide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielawska, A; Bielawski, J; Boppana, NB; DeLor, JS; Korbelik, M; Pierce, JS; Separovic, D; Van Buren, E | 1 |
| Bielawska, A; Bielawski, J; Boppana, NB; Delor, JS; Korbelik, M; Kraveka, JM; Li, LI; Pierce, JS; Rahmaniyan, M; Separovic, D; Zhang, K | 1 |
2 other study(ies) available for temoporfin and fenretinide
| Article | Year |
|---|---|
Enhanced apoptotic cancer cell killing after Foscan photodynamic therapy combined with fenretinide via de novo sphingolipid biosynthesis pathway.
Topics: Apoptosis; Cell Line, Tumor; Drug Therapy, Combination; Fenretinide; Humans; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Sphingolipids | 2016 |
Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.
Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Ceramides; Combined Modality Therapy; Endoplasmic Reticulum Stress; Fenretinide; Fumonisins; Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Pyridinium Compounds; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck | 2017 |